| Bid price | 5.75 | Open price | 6.00 |
|---|---|---|---|
| Ask price | 6.25 | Prev close | 6.00 |
| High price | 6.13 | Spread | 8.00% |
| Low price | 5.95 | Volume | 4,867 |
Register now for FREE live Phytopharm share prices, Phytopharm stock quotes, charts, trades and FREE Phytopharm company fundamentals, market news and much much more. Why not upgrade to a premium service and get Phytopharm Level 2 Data, indepth research tools and investor commentary for Phytopharm (PYM) and other London Stock Exchange equities.
Register now for FREE Phytopharm share price charts
| Name | Phytopharm | Epic | PYM |
|---|---|---|---|
| Activites | Develops pharmaceutical and functional food products based on clinical data generated from medicinal plants extracts | Reuters | PYM.L |
| ISIN | GB0006869720 | Google Finance | LON:PYM |
| Share Price (p) | 6.00 | Prev. Share Price (p) | 6.00 |
|---|---|---|---|
| Shares in Issue (m) | 347 | Market Cap (£m) | 21 |
| PE Ratio (x) | -3.41 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -2.20 | PEG |
Register now for FREE Phytopharm company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 19/01/2011 | BUY | Roger Hickling | ED | 120,000 |
| 19/01/2011 | BUY | Tim Sharpington | CEO | 120,000 |
| 31/12/2009 | BUY | Peter Blower | NED | 75,000 |
| 31/12/2009 | BUY | Alistair Taylor | CH | 150,000 |
| 31/12/2009 | BUY | Alexander(Sandy) Morrison | RES | 150,000 |
/* */ RNS Number : 1297D Phytopharm PLC 11 May 2012 11 May 2012 Phytopharm plc Update on Preclinical Study of Myogane™ in Glaucoma Phytopharm plc (PYM: London Stock Exchange) ("Phytopharm" or the "Company") today...
Phytopharm (LON:PYM) will be announcing its interim results for the six months ended 31 March 2012 on Wednesday 30 May 2012. At 11:54am: (LON:PYM) Phytopharm share price was 0p at 7.8p Story provided by StockMarketWire.com
/* */ RNS Number : 6758C Phytopharm PLC 03 May 2012 03 May 2012 Phytopharm plc Notification of results Phytopharm plc will be announcing its interim results for the six months ended 31 March...
More Phytopharm Company News >>
Register now for FREE Phytopharm company news
Listen to this very recent interview with Phytopharm CEO Dr Richard Dixey to get an overview of the company and find out what's auspicious about autumn: http://www.wallstreetreporter.com/profiles/Phytopharm.html If you like what you hear, now is a good time to buy since the share price is...
Register now for FREE Phytopharm share price discussions